Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer

Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer

Little is known regarding the effectiveness and tolerability of immune checkpoint inhibitor (ICI) rechallenge after disease progression following initial ICI treatments. To identify eligible patients for ICI rechallenge, we retrospectively analyzed the relationship between clinical profiles and the...

Full description

Bibliographic Details
Main Authors: Yuki Katayama, Takayuki Shimamoto, Tadaaki Yamada, Takayuki Takeda, Takahiro Yamada, Shinsuke Shiotsu, Yusuke Chihara, Osamu Hiranuma, Masahiro Iwasaku, Yoshiko Kaneko, Junji Uchino, Koichi Takayama
Format: Article
Language:English
Published: MDPI AG 2019-12-01
Series:Journal of Clinical Medicine
Subjects:
immunotherapy
rechallenge
non-small cell lung cancer
retrospective analysis
Online Access:https://www.mdpi.com/2077-0383/9/1/102

Internet

https://www.mdpi.com/2077-0383/9/1/102

Similar Items